查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475913

數位呼吸市場：依產品類型、最終用戶、地區 - 全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2032 年

Digital Respiratory Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 300 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本報告詳細分析了 2024 年至 2032 年數位呼吸市場的市場動態、成長因素、課題和新興趨勢。提供有關數位呼吸市場的現狀和未來前景的見解。

全球數位呼吸市場預計將從2024年的671.9億美元成長到2032年的4,000億美元，複合年增長率為25%。

重要見解

  • 預計市場規模（2024年）：671.9億美元
  • 預計市場規模（2032年）4,000億美元
  • 全球市場成長率（2024-2032年複合年增長率）：25%

數位呼吸市場 - 報告範圍：

數位呼吸包括各種基於技術的解決方案，用於管理和治療氣喘、慢性阻塞性肺病 (COPD) 和睡眠呼吸中止症等呼吸系統疾病。本報告概述了數位呼吸器採用增加的關鍵驅動因素，包括感測器技術、遠距醫療和遠端患者監測的進步。

市場驅動因素：

有幾個因素正在推動市場成長。首先，包括氣喘、慢性阻塞性肺病和阻塞性睡眠呼吸中止症在內的呼吸系統疾病的全球盛行率不斷上升，推動了對用於早期檢測、監測和管理這些疾病的數位呼吸機的需求。此外，穿戴式感測器、行動應用程式和連接裝置等數位健康解決方案的技術進步可以即時監測肺功能、氧飽和度和呼吸頻率等呼吸參數，使患者和醫療保健提供者能夠獲得可操作的見解，以實現個人化治療治療策略和及時介入。此外，呼吸系統疾病管理中對預防性護理、患者參與和自我管理的日益重視正在推動數位呼吸器的採用，特別是在服務不足和偏遠的醫療保健環境中，用於遠端監控、遠端會診和促進虛擬護理提供模式。

市場限制因素：

儘管前景樂觀，但數位呼吸市場仍面臨一定的課題。資料隱私問題、互通性問題和監管障礙等因素可能會阻礙數位呼吸器的廣泛採用和整合到現有的醫療生態系統中，從而限制其實用性和可擴展性。此外，醫療保健取得、數位素養和社會經濟地位的差異加劇了呼吸系統疾病管理和病情惡化預防方面的不平等，導致邊緣化人群中數位呼吸器的市場滲透率和採用率可能受到阻礙。此外，數位醫療技術的報銷限制、醫療報銷政策和保險範圍限制可能會影響數位呼吸市場動態、投資決策和商業化策略，對市場成長和永續性構成課題。

市場機會：

數位呼吸市場存在巨大的創新和市場拓展機會。製造商和開發人員正在尋求創建用戶友好且經濟高效的數位呼吸機，並具有無線連接、基於雲端的數據分析以及用於預測分析和個人化護理建議的人工智慧演算法等增強功能。例如，具有感測器和藍牙連接的智慧吸入器可以即時追蹤藥物依從性、吸入技術和環境觸發因素，從而提高呼吸系統疾病患者的治療依從性、吸入技術和氣喘控制。此外，與醫療保健提供者、支付者和技術合作夥伴的策略聯盟、合作夥伴關係和試點計畫將加速數位呼吸機在臨床實踐、家庭醫療保健和遠距醫療應用中的市場進入、驗證和採用。此外，在研發、臨床驗證和監管合規方面的投資將使公司能夠解決未滿足的需求、展示臨床療效並獲得數位呼吸器的監管批准，使全球的數位呼吸器能夠推動市場差異化和競爭優勢。

報告中涵蓋的關鍵問題

  • 2024年至2032年數位呼吸市場的預期複合年增長率是多少？
  • 推動數位呼吸市場成長的關鍵因素是什麼？
  • 哪種類型的數位呼吸器佔據最大的市場佔有率？
  • 誰是全球數位呼吸市場的主要參與者？
  • 主要參與者採取哪些策略來維持數位呼吸市場的競爭力？

目錄

第一章執行摘要

第二章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制

第三章市場背景

  • 市場動態
  • 情景預測
  • 機會圖分析
  • 投資可行性矩陣
  • PESTLE 與 Porter 分析
  • 監管狀況
  • 各地區母公司市場前景

第四章全球數位呼吸市場分析

  • 過去的市場規模分析（2019-2023）
  • 目前和未來的市場規模預測（2024-2032）
    • 同比增長趨勢分析
    • 絕對量機會分析

第五章全球數位呼吸市場分析：依產品

  • 簡介/主要發現
  • 過去的市場規模分析（2019-2023）：依產品
  • 目前和未來的市場規模分析和預測（2024-2032）：依產品
    • 智慧吸入器和霧化器
    • 傳感器和應用程序
  • 年比成長趨勢分析（2019-2023）：依產品
  • 絕對價值機會分析（2024-2032）：依產品

第六章全球數位呼吸市場分析：依指標分類

  • 簡介/主要發現
  • 過去的市場規模分析（2019-2023）：依指標
  • 目前和未來的市場規模分析和預測（2024-2032）：依指標
    • 哮喘
    • 慢性阻塞性肺疾病
    • 其他疾病
  • 年比成長趨勢分析（2019-2023）：依指標分類
  • 絕對機會分析（2024-2032）：依跡象分類

第七章全球數位呼吸市場分析：依最終用途

  • 簡介/主要發現
  • 歷史市場規模分析（2019-2023）：依最終用途
  • 目前與未來的市場規模分析與預測（2024-2032）：依最終用途
    • 醫院
    • 居家護理
    • 其他
  • 年比成長趨勢分析（2019-2023）：依最終用途
  • 絕對價值機會分析（2024-2032）：依最終用途

第八章全球數位呼吸市場分析：依分銷管道

  • 簡介/主要發現
  • 過去的市場規模分析（2019-2023）：依分銷管道
  • 目前和未來的市場規模分析和預測（2024-2032）：依分銷管道
    • 醫院藥房
    • 零售藥店
    • 網上藥店
  • 年比成長趨勢分析（2019-2023）：依分銷管道
  • 絕對機會分析（2024-2032）：依分銷管道

第九章全球數位呼吸市場分析：依地區

  • 介紹
  • 過去的市場規模分析（2019-2023）：依地區
  • 目前和未來的市場規模分析和預測（2024-2032）：依地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東/非洲
  • 依地區劃分的市場吸引力分析

第10章北美數位呼吸市場分析：依國家/地區

第十一章拉丁美洲數字呼吸市場分析：依國家/地區

第十二章歐洲數位呼吸市場分析：依國家分類

第十三章南亞數字呼吸市場分析：依國家分類

第14章東亞數位呼吸市場分析：依國家分類

第十五章大洋洲數位呼吸市場分析：依國家分類

第十六章中東和非洲數位呼吸市場分析：依國家/地區

第十七章 主要國家數位呼吸市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 印度
  • 馬來西亞
  • 新加坡
  • 泰國
  • 中國
  • 日本
  • 韓國
  • 澳大利亞
  • 紐西蘭
  • 海灣合作委員會國家
  • 南非
  • 以色列

第18章市場結構分析

  • 比賽儀表板
  • 競爭標桿
  • 主要參與者的市場佔有率分析

第 19 章 競爭分析

  • 衝突的衝突
    • COHERO Health Inc.
    • Cognita Labs
    • Adherium Limited
    • Amiko Digital Health Limited
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M Health Care Limited
    • AireHealth, Inc.

第 20 章假設與縮寫

第21章研究方法論

簡介目錄
Product Code: PMRREP33183

The Digital Respiratory Devices Market report by Persistence Market Research provides an in-depth analysis of market dynamics, growth factors, challenges, and emerging trends from 2024 to 2032. It offers insights into the current state and future outlook of the Digital Respiratory Devices Market.

The global digital respiratory devices market is projected to grow at a compound annual growth rate (CAGR) of 25% from USD 67.19 billion in 2024 to USD 400 billion by 2032.

Key Insights:

  • Estimated Market Size (2024): USD 67.19 Billion
  • Projected Market Size (2032): USD 400 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 25%

Digital Respiratory Devices Market - Report Scope:

Digital respiratory devices encompass a range of technology-enabled solutions used in the management and treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. The report outlines key drivers behind the increasing adoption of digital respiratory devices, including advancements in sensor technology, telemedicine, and remote patient monitoring.

Market Growth Drivers:

The market's growth is driven by several factors. Firstly, the rising prevalence of respiratory diseases, including asthma, COPD, and obstructive sleep apnea, globally, fuels demand for digital respiratory devices for early detection, monitoring, and management of these conditions. Additionally, technological advancements in digital health solutions, including wearable sensors, mobile apps, and connected devices, enable real-time monitoring of respiratory parameters such as lung function, oxygen saturation, and respiratory rate, empowering patients and healthcare providers with actionable insights for personalized treatment strategies and timely interventions. Moreover, the growing emphasis on preventive care, patient engagement, and self-management in respiratory disease management drives adoption of digital respiratory devices, facilitating remote monitoring, teleconsultations, and virtual care delivery models, particularly in underserved and remote healthcare settings.

Market Restraints:

Despite the positive outlook, the Digital Respiratory Devices Market faces certain challenges. Factors such as data privacy concerns, interoperability issues, and regulatory barriers may impede widespread adoption and integration of digital respiratory devices into existing healthcare ecosystems, limiting their utility and scalability. Moreover, disparities in healthcare access, digital literacy, and socioeconomic status may exacerbate inequalities in respiratory disease management and exacerbation prevention, hindering market penetration and adoption rates of digital respiratory devices among marginalized populations. Additionally, reimbursement limitations, healthcare reimbursement policies, and coverage restrictions for digital health technologies may impact market dynamics, investment decisions, and commercialization strategies for digital respiratory devices, posing challenges to market growth and sustainability.

Market Opportunities:

The Digital Respiratory Devices Market offers significant opportunities for innovation and market expansion. Manufacturers and developers can focus on developing user-friendly, cost-effective digital respiratory devices with enhanced features such as wireless connectivity, cloud-based data analytics, and artificial intelligence algorithms for predictive analytics and personalized care recommendations. For instance, smart inhalers equipped with sensors and Bluetooth connectivity enable real-time tracking of medication adherence, inhaler technique, and environmental triggers, enhancing treatment adherence, inhaler technique, and asthma control in patients with respiratory conditions. Moreover, strategic collaborations, partnerships, and pilot projects with healthcare providers, payers, and technology partners facilitate market access, validation, and adoption of digital respiratory devices in clinical practice, home healthcare, and telemedicine applications. Furthermore, investments in research and development, clinical validation, and regulatory compliance enable companies to address unmet needs, demonstrate clinical efficacy, and gain regulatory approvals for digital respiratory devices, driving market differentiation and competitive advantage in the global digital respiratory devices market.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the Digital Respiratory Devices Market from 2024 to 2032?
  • What are the Key Factors Driving the Growth of the Digital Respiratory Devices Market?
  • Which Type of Digital Respiratory Device Holds the Largest Market Share?
  • Who are the Key Players in the Global Digital Respiratory Devices Market?
  • What Strategies are Adopted by Leading Companies to Stay Competitive in the Digital Respiratory Devices Market?

Competitive Landscape and Business Strategies:

Key players in the Digital Respiratory Devices Market include Propeller Health (a ResMed Company), Adherium Limited, Teva Pharmaceuticals Industries Ltd., Cohero Health, and NuvoAir, among others. These companies focus on product innovation, strategic partnerships, and market expansion to maintain a competitive edge in the market. For instance, Propeller Health offers a range of digital health solutions for asthma and COPD management, including sensor-enabled inhaler devices, mobile apps, and population health analytics platforms, while Adherium Limited specializes in smart medication adherence solutions for respiratory diseases. Market players also invest in clinical trials, real-world evidence generation, and regulatory approvals to demonstrate clinical efficacy, safety, and value proposition of digital respiratory devices, fostering adoption by healthcare providers, payers, and patients in the global market.

Key Companies Profiled:

  • COHERO Health Inc.
  • Cognita Labs
  • Adherium limited
  • Amiko Digital Health Limited
  • Teva pharmaceuticals industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3m Health Care Limited
  • AireHealth, Inc.

Digital Respiratory Devices Market Segmentation:

By Product

  • Smart Inhalers & Nebulizers
  • Sensors & Apps

By Indication

  • Asthma
  • COPD
  • Other Diseases

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End Use

  • Hospitals
  • Homecare Settings
  • Other settings

By Region

  • North America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Smart inhalers & Nebulizers
    • 5.3.2. Sensors & Apps
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Indication

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2024-2032
    • 6.3.1. Asthma
    • 6.3.2. COPD
    • 6.3.3. Other Diseases
  • 6.4. Y-o-Y Growth Trend Analysis By Indication, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Indication, 2024-2032

7. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By End-Use

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By End-Use , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-Use , 2024-2032
    • 7.3.1. Hospitals
    • 7.3.2. Homecare Settings
    • 7.3.3. Other settings
  • 7.4. Y-o-Y Growth Trend Analysis By End-Use , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By End-Use , 2024-2032

8. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Distribution Channel

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2032
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024-2032

9. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. South Asia
    • 9.3.5. East Asia
    • 9.3.6. Oceania
    • 9.3.7. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Indication
    • 10.2.4. By End-Use
    • 10.2.5. By Distribution Channel
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Indication
    • 10.3.4. By End-Use
    • 10.3.5. By Distribution Channel
  • 10.4. Key Takeaways

11. Latin America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Indication
    • 11.2.4. By End-Use
    • 11.2.5. By Distribution Channel
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Indication
    • 11.3.4. By End-Use
    • 11.3.5. By Distribution Channel
  • 11.4. Key Takeaways

12. Europe Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Indication
    • 12.2.4. By End-Use
    • 12.2.5. By Distribution Channel
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End-Use
    • 12.3.5. By Distribution Channel
  • 12.4. Key Takeaways

13. South Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Malaysia
      • 13.2.1.3. Singapore
      • 13.2.1.4. Thailand
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Product
    • 13.2.3. By Indication
    • 13.2.4. By End-Use
    • 13.2.5. By Distribution Channel
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End-Use
    • 13.3.5. By Distribution Channel
  • 13.4. Key Takeaways

14. East Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. China
      • 14.2.1.2. Japan
      • 14.2.1.3. South Korea
    • 14.2.2. By Product
    • 14.2.3. By Indication
    • 14.2.4. By End-Use
    • 14.2.5. By Distribution Channel
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End-Use
    • 14.3.5. By Distribution Channel
  • 14.4. Key Takeaways

15. Oceania Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. Australia
      • 15.2.1.2. New Zealand
    • 15.2.2. By Product
    • 15.2.3. By Indication
    • 15.2.4. By End-Use
    • 15.2.5. By Distribution Channel
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End-Use
    • 15.3.5. By Distribution Channel
  • 15.4. Key Takeaways

16. MEA Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 16.2.1. By Country
      • 16.2.1.1. GCC Countries
      • 16.2.1.2. South Africa
      • 16.2.1.3. Israel
      • 16.2.1.4. Rest of MEA
    • 16.2.2. By Product
    • 16.2.3. By Indication
    • 16.2.4. By End-Use
    • 16.2.5. By Distribution Channel
  • 16.3. Market Attractiveness Analysis
    • 16.3.1. By Country
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End-Use
    • 16.3.5. By Distribution Channel
  • 16.4. Key Takeaways

17. Key Countries Digital Respiratory Devices Market Analysis

  • 17.1. U.S.
    • 17.1.1. Pricing Analysis
    • 17.1.2. Market Share Analysis, 2023
      • 17.1.2.1. By Product
      • 17.1.2.2. By Indication
      • 17.1.2.3. By End-Use
      • 17.1.2.4. By Distribution Channel
  • 17.2. Canada
    • 17.2.1. Pricing Analysis
    • 17.2.2. Market Share Analysis, 2023
      • 17.2.2.1. By Product
      • 17.2.2.2. By Indication
      • 17.2.2.3. By End-Use
      • 17.2.2.4. By Distribution Channel
  • 17.3. Brazil
    • 17.3.1. Pricing Analysis
    • 17.3.2. Market Share Analysis, 2023
      • 17.3.2.1. By Product
      • 17.3.2.2. By Indication
      • 17.3.2.3. By End-Use
      • 17.3.2.4. By Distribution Channel
  • 17.4. Mexico
    • 17.4.1. Pricing Analysis
    • 17.4.2. Market Share Analysis, 2023
      • 17.4.2.1. By Product
      • 17.4.2.2. By Indication
      • 17.4.2.3. By End-Use
      • 17.4.2.4. By Distribution Channel
  • 17.5. Germany
    • 17.5.1. Pricing Analysis
    • 17.5.2. Market Share Analysis, 2023
      • 17.5.2.1. By Product
      • 17.5.2.2. By Indication
      • 17.5.2.3. By End-Use
      • 17.5.2.4. By Distribution Channel
  • 17.6. U.K.
    • 17.6.1. Pricing Analysis
    • 17.6.2. Market Share Analysis, 2023
      • 17.6.2.1. By Product
      • 17.6.2.2. By Indication
      • 17.6.2.3. By End-Use
      • 17.6.2.4. By Distribution Channel
  • 17.7. France
    • 17.7.1. Pricing Analysis
    • 17.7.2. Market Share Analysis, 2023
      • 17.7.2.1. By Product
      • 17.7.2.2. By Indication
      • 17.7.2.3. By End-Use
      • 17.7.2.4. By Distribution Channel
  • 17.8. Spain
    • 17.8.1. Pricing Analysis
    • 17.8.2. Market Share Analysis, 2023
      • 17.8.2.1. By Product
      • 17.8.2.2. By Indication
      • 17.8.2.3. By End-Use
      • 17.8.2.4. By Distribution Channel
  • 17.9. Italy
    • 17.9.1. Pricing Analysis
    • 17.9.2. Market Share Analysis, 2023
      • 17.9.2.1. By Product
      • 17.9.2.2. By Indication
      • 17.9.2.3. By End-Use
      • 17.9.2.4. By Distribution Channel
  • 17.10. India
    • 17.10.1. Pricing Analysis
    • 17.10.2. Market Share Analysis, 2023
      • 17.10.2.1. By Product
      • 17.10.2.2. By Indication
      • 17.10.2.3. By End-Use
      • 17.10.2.4. By Distribution Channel
  • 17.11. Malaysia
    • 17.11.1. Pricing Analysis
    • 17.11.2. Market Share Analysis, 2023
      • 17.11.2.1. By Product
      • 17.11.2.2. By Indication
      • 17.11.2.3. By End-Use
      • 17.11.2.4. By Distribution Channel
  • 17.12. Singapore
    • 17.12.1. Pricing Analysis
    • 17.12.2. Market Share Analysis, 2023
      • 17.12.2.1. By Product
      • 17.12.2.2. By Indication
      • 17.12.2.3. By End-Use
      • 17.12.2.4. By Distribution Channel
  • 17.13. Thailand
    • 17.13.1. Pricing Analysis
    • 17.13.2. Market Share Analysis, 2023
      • 17.13.2.1. By Product
      • 17.13.2.2. By Indication
      • 17.13.2.3. By End-Use
      • 17.13.2.4. By Distribution Channel
  • 17.14. China
    • 17.14.1. Pricing Analysis
    • 17.14.2. Market Share Analysis, 2023
      • 17.14.2.1. By Product
      • 17.14.2.2. By Indication
      • 17.14.2.3. By End-Use
      • 17.14.2.4. By Distribution Channel
  • 17.15. Japan
    • 17.15.1. Pricing Analysis
    • 17.15.2. Market Share Analysis, 2023
      • 17.15.2.1. By Product
      • 17.15.2.2. By Indication
      • 17.15.2.3. By End-Use
      • 17.15.2.4. By Distribution Channel
  • 17.16. South Korea
    • 17.16.1. Pricing Analysis
    • 17.16.2. Market Share Analysis, 2023
      • 17.16.2.1. By Product
      • 17.16.2.2. By Indication
      • 17.16.2.3. By End-Use
      • 17.16.2.4. By Distribution Channel
  • 17.17. Australia
    • 17.17.1. Pricing Analysis
    • 17.17.2. Market Share Analysis, 2023
      • 17.17.2.1. By Product
      • 17.17.2.2. By Indication
      • 17.17.2.3. By End-Use
      • 17.17.2.4. By Distribution Channel
  • 17.18. New Zealand
    • 17.18.1. Pricing Analysis
    • 17.18.2. Market Share Analysis, 2023
      • 17.18.2.1. By Product
      • 17.18.2.2. By Indication
      • 17.18.2.3. By End-Use
      • 17.18.2.4. By Distribution Channel
  • 17.19. GCC Countries
    • 17.19.1. Pricing Analysis
    • 17.19.2. Market Share Analysis, 2023
      • 17.19.2.1. By Product
      • 17.19.2.2. By Indication
      • 17.19.2.3. By End-Use
      • 17.19.2.4. By Distribution Channel
  • 17.20. South Africa
    • 17.20.1. Pricing Analysis
    • 17.20.2. Market Share Analysis, 2023
      • 17.20.2.1. By Product
      • 17.20.2.2. By Indication
      • 17.20.2.3. By End-Use
      • 17.20.2.4. By Distribution Channel
  • 17.21. Israel
    • 17.21.1. Pricing Analysis
    • 17.21.2. Market Share Analysis, 2023
      • 17.21.2.1. By Product
      • 17.21.2.2. By Indication
      • 17.21.2.3. By End-Use
      • 17.21.2.4. By Distribution Channel

18. Market Structure Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Market Share Analysis of Top Players
    • 18.3.1. By Regional
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End-Use
    • 18.3.5. By Distribution Channel

19. Competition Analysis

  • 19.1. Competition Deep Dive
    • 19.1.1. COHERO Health Inc.
      • 19.1.1.1. Overview
      • 19.1.1.2. Product Portfolio
      • 19.1.1.3. Profitability by Market Segments
      • 19.1.1.4. Sales Footprint
      • 19.1.1.5. Strategy Overview
        • 19.1.1.5.1. Marketing Strategy
    • 19.1.2. Cognita Labs
      • 19.1.2.1. Overview
      • 19.1.2.2. Product Portfolio
      • 19.1.2.3. Profitability by Market Segments
      • 19.1.2.4. Sales Footprint
      • 19.1.2.5. Strategy Overview
        • 19.1.2.5.1. Marketing Strategy
    • 19.1.3. Adherium Limited
      • 19.1.3.1. Overview
      • 19.1.3.2. Product Portfolio
      • 19.1.3.3. Profitability by Market Segments
      • 19.1.3.4. Sales Footprint
      • 19.1.3.5. Strategy Overview
        • 19.1.3.5.1. Marketing Strategy
    • 19.1.4. Amiko Digital Health Limited
      • 19.1.4.1. Overview
      • 19.1.4.2. Product Portfolio
      • 19.1.4.3. Profitability by Market Segments
      • 19.1.4.4. Sales Footprint
      • 19.1.4.5. Strategy Overview
        • 19.1.4.5.1. Marketing Strategy
    • 19.1.5. Teva Pharmaceuticals Industries Ltd.
      • 19.1.5.1. Overview
      • 19.1.5.2. Product Portfolio
      • 19.1.5.3. Profitability by Market Segments
      • 19.1.5.4. Sales Footprint
      • 19.1.5.5. Strategy Overview
        • 19.1.5.5.1. Marketing Strategy
    • 19.1.6. Propeller Health
      • 19.1.6.1. Overview
      • 19.1.6.2. Product Portfolio
      • 19.1.6.3. Profitability by Market Segments
      • 19.1.6.4. Sales Footprint
      • 19.1.6.5. Strategy Overview
        • 19.1.6.5.1. Marketing Strategy
    • 19.1.7. Novartis AG
      • 19.1.7.1. Overview
      • 19.1.7.2. Product Portfolio
      • 19.1.7.3. Profitability by Market Segments
      • 19.1.7.4. Sales Footprint
      • 19.1.7.5. Strategy Overview
        • 19.1.7.5.1. Marketing Strategy
    • 19.1.8. Pneuma Respiratory Inc.
      • 19.1.8.1. Overview
      • 19.1.8.2. Product Portfolio
      • 19.1.8.3. Profitability by Market Segments
      • 19.1.8.4. Sales Footprint
      • 19.1.8.5. Strategy Overview
        • 19.1.8.5.1. Marketing Strategy
    • 19.1.9. 3M Health Care Limited
      • 19.1.9.1. Overview
      • 19.1.9.2. Product Portfolio
      • 19.1.9.3. Profitability by Market Segments
      • 19.1.9.4. Sales Footprint
      • 19.1.9.5. Strategy Overview
        • 19.1.9.5.1. Marketing Strategy
    • 19.1.10. AireHealth, Inc.
      • 19.1.10.1. Overview
      • 19.1.10.2. Product Portfolio
      • 19.1.10.3. Profitability by Market Segments
      • 19.1.10.4. Sales Footprint
      • 19.1.10.5. Strategy Overview
        • 19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology